* p ≤ 0.05
References:
1. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003;326(7404):1423.
2. Helin-Salmivaara A, Lavikainen P, Korhonen MJ, et al. Long-term persistence with statin therapy: a nationwide register study in Finland.Clin Ther. 2008;30 Pt 2:2228-2240.
3. Lemstra M, Alsabbagh W. Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis. Patient Preference and Adherence. 2014:211.
4. Evans CD, Eurich DT, Lamb DA, et al. Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada. J Manag Care Pharm.2009;15(6):476-484.
5. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients.JAMA. 2002;288(4):455-461.
6. Sung JC, Nichol MB, Venturini F, Bailey KL, McCombs JS, Cody M. Factors affecting patient compliance with antihyperlipidemic medications in an HMO population. Am J Manag Care. 1998;4(10):1421-1430.
7. Aubert RE, Yao J, Xia F, Garavaglia SB. Is there a relationship between early statin compliance and a reduction in healthcare utilization? Am J Manag Care. 2010;16(6):459-466.
8. Guthrie RM. The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program. Clin Ther. 2001;23(6):970-980.
9. World Health O. Adherence to long-term therapies : evidence for action / [edited by Eduardo Sabaté]. In. Geneva: World Health Organization; 2003.
10. Perreault S, Dragomir A, Blais L, et al. Impact of better adherence to statin agents in the primary prevention of coronary artery disease.Eur J Clin Pharmacol. 2009;65(10):1013-1024.
11. Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013;8(12):e80633.
12. Corrao G, Conti V, Merlino L, Catapano AL, Mancia G. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.Clin Ther. 2010;32(2):300-310.
13. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost.Med Care. 2005;43(6):521-530.
14. Brummel A, Carlson AM. Comprehensive Medication Management and Medication Adherence for Chronic Conditions. Journal of Managed Care & Specialty Pharmacy. 2016;22(1):56-62.
15. Deshpande S, Quek RG, Forbes CA, et al. A systematic review to assess adherence and persistence with statins. Curr Med Res Opin.2017;33(4):769-778.
16. Fernandez-Lazaro CI, Garcia-Gonzalez JM, Adams DP, et al. Adherence to treatment and related factors among patients with chronic conditions in primary care: a cross-sectional study. BMC Fam Pract.2019;20(1):132.
17. Schedlbauer A, Schroeder K, Peters TJ, Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev. 2004(4):CD004371.
18. Stuurman-Bieze AG, Hiddink EG, van Boven JF, Vegter S. Proactive pharmaceutical care interventions improve patients’ adherence to lipid-lowering medication. Ann Pharmacother.2013;47(11):1448-1456.
19. Kamal AK, Khalid W, Muqeet A, et al. Making prescriptions ”talk” to stroke and heart attack survivors to improve adherence: Results of a randomized clinical trial (The Talking Rx Study). PLoS One.2018;13(12):e0197671.
20. Ofori-Asenso R, Jakhu A, Zomer E, et al. Adherence and Persistence Among Statin Users Aged 65 Years and Over: A Systematic Review and Meta-analysis. J Gerontol A Biol Sci Med Sci. 2018;73(6):813-819.
21. Chee YJ, Chan HH, Tan NC. Understanding patients’ perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review. Singapore Med J.2014;55(8):416-421.
22. Warren JR, Falster MO, Tran B, Jorm L. Association of Continuity of Primary Care and Statin Adherence. PLoS One.2015;10(10):e0140008.
23. van Houtum L, Heijmans M, Rijken M, Groenewegen P. Perceived quality of chronic illness care is associated with self-management: Results of a nationwide study in the Netherlands. Health Policy.2016;120(4):431-439.
24. Gardner AJ, Gray AL, Self S, Wagener JS. Strengthening care teams to improve adherence in cystic fibrosis: a qualitative practice assessment and quality improvement initiative. Patient Prefer Adherence.2017;11:761-767.
25. De Geest S, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med.2018;169(1):30-35.
26. Huiskes VJB, van den Ende CHM, van Dijk L, Burger DM, van den Bemt BJF. Association between healthcare practitioners’ beliefs about statins and patients’ beliefs and adherence. Br J Clin Pharmacol.2021;87(3):1082-1088.
27. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691-705.
28. de Bruin M, Viechtbauer W, Hospers HJ, Schaalma HP, Kok G. Standard care quality determines treatment outcomes in control groups of HAART-adherence intervention studies: implications for the interpretation and comparison of intervention effects. Health Psychol. 2009;28(6):668-674.
29. de Bruin M, Viechtbauer W, Schaalma HP, Kok G, Abraham C, Hospers HJ. Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials. Arch Intern Med. 2010;170(3):240-250.
30. Tommelein E, Mehuys E, Van Tongelen I, Brusselle G, Boussery K. Accuracy of the Medication Adherence Report Scale (MARS-5) as a quantitative measure of adherence to inhalation medication in patients with COPD. Ann Pharmacother. 2014;48(5):589-595.
31. Salt E, Frazier SK. Predictors of Medication Adherence in Patients with Rheumatoid Arthritis. Drug Dev Res. 2011;72(8):756-763.
32. Butler JA, Peveler RC, Roderick P, Horne R, Mason JC. Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring.Transplantation. 2004;77(5):786-789.
33. Mardby AC, Akerlind I, Jorgensen T. Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns. 2007;69(1-3):158-164.
34. Nicklas LB, Dunbar M, Wild M. Adherence to pharmacological treatment of non-malignant chronic pain: the role of illness perceptions and medication beliefs. Psychol Health. 2010;25(5):601-615.
35. Sutton S, Kinmonth AL, Hardeman W, et al. Does electronic monitoring influence adherence to medication? Randomized controlled trial of measurement reactivity. Ann Behav Med. 2014;48(3):293-299.
36. Timmers L, Boons CC, Verbrugghe M, van den Bemt BJ, Van Hecke A, Hugtenburg JG. Supporting adherence to oral anticancer agents: clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists. BMC Cancer.2017;17(1):122.
37. Wouters H, Van Dijk L, Geers HC, et al. Understanding Statin Non-Adherence: Knowing Which Perceptions and Experiences Matter to Different Patients. PLoS One. 2016;11(1):e0146272.
38. Kooij MJ, Heerdink ER, van Dijk L, van Geffen EC, Belitser SV, Bouvy ML. Effects of Telephone Counseling Intervention by Pharmacists (TelCIP) on Medication Adherence; Results of a Cluster Randomized Trial.Front Pharmacol. 2016;7:269.
39. Berglund E, Lytsy P, Westerling R. Adherence to and beliefs in lipid-lowering medical treatments: a structural equation modeling approach including the necessity-concern framework. Patient Educ Couns. 2013;91(1):105-112.